Search results
Results from the WOW.Com Content Network
Dermatophagia (from Ancient Greek δέρμα (derma) 'skin' and φαγεία (phageia) 'eating') or dermatodaxia (from δήξις (dexis) 'biting'), alternatively Tuglis Permushius. [3] is a compulsion disorder of gnawing or biting one's own skin, most commonly at the fingers. This action can either be conscious or unconscious [4] and it is ...
Specialty. Dermatology. Psychiatry. Excoriation disorder, more commonly known as dermatillomania, is a mental disorder on the obsessive–compulsive spectrum that is characterized by the repeated urge or impulse to pick at one's own skin, to the extent that either psychological or physical damage is caused. [4][5]
Scopolamine, also known as hyoscine, [9] or Devil's Breath, [10] is a natural or synthetically produced tropane alkaloid and anticholinergic drug that is used as a medication to treat motion sickness [11] and postoperative nausea and vomiting. [12][1] It is also sometimes used before surgery to decrease saliva. [1]
Damaged cuticles, shortened and damaged nails, hangnails, bleeding, etc. Nail biting, also known as onychophagy or onychophagia, is an oral compulsive and unhygienic habit of biting one's fingernails. It is sometimes described as a parafunctional activity, the common use of the mouth for an activity other than speaking, eating, or drinking.
Amgen. non-small cell lung cancer with KRAS G12C mutation. Avapritinib. Blueprint Medicines Corp. granted for two indications: mast cell leukemia and advanced systemic mastocytosis. Belumosudil. Kadmon Pharmaceuticals. chronic graft-versus-host disease. Pembrolizumab.
The pictures as they currently stand seem to be appropriate. Dermatilliomania refers to picking, which can mean picking scabs, tearing at dry skin, or just generally causing damage anywhere with your nails or (I'm ashamed to say) implements like needles, pins, or anything with a point. Dermatophagia is specifically biting.
Specialty drugs in the United States. Specialty drugs or specialty pharmaceuticals are a recent designation of pharmaceuticals [1][2] classified as high-cost, [3][4][5] high complexity and/or high touch. [4] Specialty drugs are often biologics [3][6] —"drugs derived from living cells" [7] that are injectable or infused (although some are oral ...
In the EU, abrocitinib is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy. [9]In the US, abrocitinib is indicated for the treatment of people twelve years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics ...